Sera Prognostics remains in an early commercial stage with limited revenue growth—$81,000 in 2025—and persistent operating losses exceeding $36 million annually. The company’s cash flow deteriorated significantly in 2025, reflecting ongoing expenditure to support growth initiatives. Recent executive additions focused on marketing underscore a strategic shift toward commercial expansion despite financial headwinds. Liquidity appears sufficient near term with a current ratio of 1.69, but risks related to sustained negative cash flows and uncertain competitive positioning remain significant. Progress depends on successful commercialization execution and achievement of operational milestones.